Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maria Isabel Benitez Carabante"'
Autor:
Laura Alonso García, David Bueno Sánchez, Jose Maria Fernández Navarro, Alexandra Regueiro Garcia, Miguel Blanquer Blanquer, Maria Isabel Benitez Carabante, Yasmina Mozo del Castillo, Jose Luis Fuster Soler, Maria Luz Uria Oficialdegui, Luisa Sisinni, Antonio Perez Martinez, Cristina Diaz de Heredia Rubio
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionHematopoietic stem cell transplantation (HCT) can cure chronic granulomatous disease (CGD). However, transplant-associated morbidity or mortality may occur, and it is still controversial which patients benefit from this procedure. The aim
Externí odkaz:
https://doaj.org/article/409bf789b55a428e9e3203e01467554b
Autor:
Matthias Wölfl, Muna Qayed, Maria Isabel Benitez Carabante, Tomas Sykora, Halvard Bonig, Anita Lawitschka, Cristina Diaz-de-Heredia
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2022)
Acute graft-versus-host disease (aGvHD) continues to be a leading cause of morbidity and mortality following allogeneic haematopoietic stem cell transplantation (HSCT). However, higher event-free survival (EFS) was observed in patients with acute lym
Externí odkaz:
https://doaj.org/article/f72dab38c911438297cfe51ccee6ee41
Autor:
Virginia Escamilla Gomez, Valentín García Gutiérrez, Beatriz Astibia Mahillo, Patricia Alcalde, Lucía López Corral, Marina Acera Gómez, Melissa Torres, Asunción Borrego Borrego, Leslie González Pinedo, Maite Zudaire, Marta González Vicent, Ana Benzaquén, Isabel Izquierdo Garcia, Pedro Asensi, Juan Montoro Gómez, Guillermo Orti Pascual, David Valcárcel, Maria Isabel Benitez Carabante, Cristina Díaz de Heredia Rubio, Eloi Cañamero Giro, Christelle Ferrà, Irene García-Cadenas, Sara Redondo, Luisa Sisinni, Antonio Perez, Alberto Mussetti, Lucía García, María Del Pilar Palomo Moraleda, Pedro Antonio González Sierra, Manuel Jurado Chacón, Jose A. Perez-Simon
Publikováno v:
Blood. 140:7754-7756
Autor:
Laura Murillo Sanjuán, María Luz Uria-Oficialdegui, Gloria Hidalgo-Gómez, Laura Alonso García, Melissa Panesso Romero, María Isabel Benítez Carabante, Margarita Ortega Blanco, Cristina Díaz-De-Heredia
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100074- (2023)
Externí odkaz:
https://doaj.org/article/4dd4add049d249548e51404e66edc1fa
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
José María Valle-T-Figueras, Berta Renedo Miró, Maria Isabel Benítez Carabante, Cristina Díaz-de-Heredia, Jaume Vima Bofarull, Natalia Mendoza-Palomar, Maria Teresa Martín-Gómez, Pere Soler-Palacín
Publikováno v:
Journal of Fungi, Vol 7, Iss 6, p 456 (2021)
Voriconazole plasma concentrations (PC) are highly variable, particularly in children. Dose recommendations in 2–12-year-old patients changed in 2012. Little data on therapeutic drug monitoring (TDM) after these new recommendations are available. W
Externí odkaz:
https://doaj.org/article/a33c36d0646b46b9bce66fb25e60e2e6
Autor:
Maria Pérez-Torres Lobato, Maria Isabel Benitez-Carabante, Laura Alonso, Silvia Torrents, Nerea Castillo Flores, Maria Luz Uria Oficialdegui, Melissa Panesso, Carla Alonso-Martínez, Maria Oliveras, Berta Renedo-Miró, Joaquim Vives, Cristina Diaz-de-Heredia
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
ObjectivesTo describe mesenchymal stromal cells (MSCs) in the treatment of hematopoietic stem cell transplantation (HSCT) complications and to assess its safety and efficacy.MethodsSingle-center retrospective study (2016–2023). Patients under 20 ye
Externí odkaz:
https://doaj.org/article/5c9817e1ba0f4f778aa9a7437b09af73
Autor:
Laura Gomez-Ganda, Maria Isabel Benitez-Carabante, Aurora Fernandez-Polo, Marina Muñoz-Lopez, Berta Renedo-Miro, Gema Ariceta, Cristina Diaz De Heredia
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Background: Transplant-associated thrombotic microangiopathy (TA-TMA) is a serious complication of hematopoietic stem cell transplantation (HSCT) associated with high morbidity and mortality. High-risk TA-TMA (hrTA-TMA) is characterized by multifacto
Externí odkaz:
https://doaj.org/article/6f0a3f045b8d45d78d16fcb7bd192de4